Shuangshuang Wu

A type I and type II chemical biology toolbox to overcome the hypoxic tumour microenvironment for photodynamic therapy

Minzi Ju, Lu Yang, Guowei Wang et al. · Biomaterials Science · 2024 · 29 citations

Medicine, Chemical Biology, Oncology +16

c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia

Shuang Liu, Xinan Qiao, Shuangshuang Wu et al. · APOPTOSIS · 2022 · 26 citations

Medicine, Oncology, Pharmacology +17

Venetoclax enhances DNA damage induced by XPO1 inhibitors: A novel mechanism underlying the synergistic antileukaemic effect in acute myeloid leukaemia

Hanxi Yu, Shuangshuang Wu, Shuang Liu et al. · Journal of Cellular and Molecular Medicine · 2022 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17

The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia

Yongwei Su, Jenna L. Carter, Xinyu Li et al. · Cancer Research · 2024 · 21 citations · Full text

Medicine, Oncology, Pharmacology +16

Panobinostat sensitizes AraC-resistant AML cells to the combination of azacitidine and venetoclax

Jianlei Zhao, Shuangshuang Wu, Deying Wang et al. · Biochemical Pharmacology · 2024 · 14 citations · Full text

Medicine, Oncology, Pharmacology +5